Skip to main content
Tech.euFundingExplorerBeta

Takeda Ventures

Investor profile

Corporate VC

Takeda Ventures has backed 6 European tech companies across 8 funding rounds between 2005 and 2025, joining rounds totalling €76M. Most active in Healthtech and Fintech. Data as of Nov 2026.

Deals
8
distinct rounds
Companies
6
backed
Active span
2005–2025
21 yrs
Total round €
€76M
sum of rounds joined

Deals by year

distinct rounds / year
Takeda Ventures — deals by year — interactive chart.
Data table
Takeda Ventures — deals by year
20051
20151
20172
20211
20222
20251

Top sectors

by deals
Takeda Ventures — top sectors — interactive chart.
Data table
Takeda Ventures — top sectors
Healthtech8
Fintech1

Stages

by deals
Takeda Ventures — stages — interactive chart.
Data table
Takeda Ventures — stages
Other3
Series A2
Early VC1
Seed1
Series D+1

Countries

by deals
Takeda Ventures — countries — interactive chart.
Data table
Takeda Ventures — countries
Belgium2
Spain2
Denmark1
Israel1
Netherlands1
Norway1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Takeda Ventures — 8 dealsTakeda VenturesAdBio partners — 1 shared deals · click to openAdBio partnersAdvent France Biotechnology — 1 shared deals · click to openAdvent France BiotechnologyCDTI Innvierte — 1 shared deals · click to openCDTI InnvierteColumbus Venture Partners — 1 shared deals · click to openColumbus Venture PartnersDemcon Investment — 1 shared deals · click to openDemcon InvestmentDutch Government — 1 shared deals · click to openDutch GovernmentEIC Fund — 1 shared deals · click to openEIC FundEssex Woodlands Health Ventures — 1 shared deals · click to openEssex Woodlands Health VenturesGilde Healthcare — 1 shared deals · click to openGilde Healthcarei&i Biotech Fund — 1 shared deals · click to openi&i Biotech FundInnovation SBI Japan-Israel Innovation Fund — 1 shared deals · click to openInnovation SBI Japan-Israel Innovation FundInvivo Capita I — 1 shared deals · click to openInvivo Capita IInvivo Capital Partners — 1 shared deals · click to openInvivo Capital PartnersJohnson & Johnson — 1 shared deals · click to openJohnson & JohnsonMirae Asset Venture Investment — 1 shared deals · click to openMirae Asset Venture InvestmentNovalis Biotech — 1 shared deals · click to openNovalis BiotechNovo A — 1 shared deals · click to openNovo AOost NL — 1 shared deals · click to openOost NL

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
BiomXIsrael1€22M
SymphogenDenmark1€21M
Integra TherapeuticsSpain2€15M
EnzyreNetherlands1€12M
UnivercellsBelgium2€6.0M
Zelluna ImmunotherapyNorway1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
BiomXSeries A€22M2017-05
SymphogenSeries D+€21M2006-01
EnzyreSeries A€12M2022-11
Integra TherapeuticsSeed€11M2025-09
Integra TherapeuticsOther€4.5M2021-12
UnivercellsOther€3.0M2017-04
UnivercellsEarly VC€3.0M2015-10
← Back to investors